For complete details, including source material, refer to the full study.
Excerpted and adapted from:
Aymon R, Mongin D, Guemara R, et al. Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with jak inhibitors compared with biologic disease-modifying antirheumatic drugs: Data from an international collaboration of registries. Arthritis Rheumatol. 2025 Aug;77(9).